PQ 251
251. Deputy John McGuinness asked the Minister for Health the differences in the way in which persons with multiple sclerosis, MS, here access life changing medicines by comparison to other EU countries; the reason there is delay for new medicine to be reimbursed here; and if he will make a statement on the matter. [17285/18]
Introduced
19 April 2018
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
19 April 2018
Summary
251. Deputy John McGuinness asked the Minister for Health the differences in the way in which persons with multiple sclerosis, MS, here access life changing medicines by comparison to other EU countries; the reason there is delay for new medicine to be reimbursed here; and if he will make a statement on the matter. [17285/18]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 19 April 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2018-04-19/251/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2018-04-19/pq_251